Almost 80% of US nurses worry about infecting loved ones with COVID-19

A national sampling of more than 15,000 nurses, nearly 90% of them RNs, is collectively reporting “infecting family and friends” as the profession’s single most pressing concern during the COVID-19 crisis.

Some 79% see that as one their top three sources of distress regarding the present public-health crisis.

The findings are from a survey conducted by the staffing firm NurseGrid over a seven-day period ending April 19.

Following the family-and-friends concern were becoming infected while at work (61%), burnout (28%), mental health (27%), public complacency (23%), well-being of colleagues and/or delivering poor care (tied at 22%), and life after the pandemic (19%).

Some 89% of respondents work at facilities actively treating COVID-19 patients, NurseGrid reports, and 38% have been reassigned to focus on these patients.

The staffing organization also asked about shortages of supplies and equipment. New N95 masks are way out ahead on that score, named by 84% of respondents. A concerning 35% report staff shortages, while 32% name ventilators and 31% proper training.

Nearly half the hospitals represented are in need of tests for staff, and about a third don’t have enough for patients.

NurseGrid has posted the results online in infographic format, along with a separate webpage offering interactive maps, graphs and charts.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.